Johnson & Johnson

Oregon judge sides with J&J, overturning $260M talc verdict

After a jury awarded $260M to a woman who claimed that her use of J&J’s talc powder caused her mesothelioma, a state judge has overturned the verdict.

Kevin Dunleavy Sep 17, 2024 8:17am

Akeso-Summit, BIOSECURE, Candid and more—Fierce Pharma Asia

Sep 13, 2024 8:53am

Tremfya enters crowded ulcerative colitis arena with FDA nod

Sep 11, 2024 6:58pm

J&J builds case for Tagrisso rival with survival analysis

Sep 8, 2024 2:07pm

J&J nears talc settlement after adding $1.1B to the pot: Reuters

Sep 5, 2024 10:56am

J&J ushers in new 340B rebate policy for Stelara, Xarelto

Aug 26, 2024 11:23am